Delivery Order SPE2DB22D1106-SPE2DB23FEFA1
Award Date 4/25/23
Potential Completion Date 4/26/23
Potential Value $3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Omnipaque 350 mg/ml pluspak 500ml, a contrast agent used in medical imaging procedures. The $1,399.28 firm-fixed-price contract has a period of performance through July 30, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued up to $999,999,999...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Omnipaque 350 mg/ml infusion bottles (100 ml), a radiographic contrast agent used in medical imaging procedures. The contract is a Delivery Order with a Firm Fixed Price of $1,653.50 and an ultimate completion date of April 18, 2024. There is no set-aside designation, indicating open...
- The Defense Logistics Agency awarded a delivery order valued at $2,946.42 to AmerisourceBergen Drug Corp for the supply of Omnipaque 350 mg/ml Pluspak 500ml, a contrast imaging agent used in diagnostic medical procedures. This non-set-aside, competitively awarded contract carries a firm fixed price structure with an ultimate completion date of December 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will fulfill performance at its...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The award, valued at $2,218.08, is for the delivery of Omnipaque 300 mg/mL medical imaging contrast media, which is used to enhance the visibility of internal body structures during medical procedures. The contract is a firm-fixed-price delivery order with a period of performance ending on September 24, 2024. It is not designated as...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,322.80 firm-fixed-price contract is for the supply of Omnipaque 350 mg/ml infusion bottles (100 ml). The contract has an ultimate completion date of January 19, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency awarded a $1,622.85 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for Omnipaque 300 mg/ml infusion bottles (100ml units). The contract, which is non-set-aside and competitively awarded, is scheduled for completion by August 5, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- This federal contract award is for the delivery of Omnipaque 350 mg/ml infusion bottles (150 ml) to the Defense Logistics Agency (DLA). The $1,783.80 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 25, 2022 and was awarded on January 24, 2022. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,577.72, is a delivery order for the supply of OMNIPAQUE 350 MG/ML INFU BTL 100ML, a medical imaging agent. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,690.80 contract is for the delivery of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a medical product. The contract has a completion date of June 16, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a $6,378.55 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a medical product, with a period of performance through June 17, 2024. This order is part of AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...